Comments
Loading...
Standard BioTools (LAB) Forecast
NewsEarningsStandard BioTools (LAB) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestStandard BioTools (NASDAQ:LAB) Stock Quotes, Forecast and News Summary
Standard BioTools Stock (NASDAQ: LAB) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Standard BioTools (LAB) stock?
You can purchase shares of Standard BioTools (NASDAQ:LAB) through any online brokerage.
Who are Standard BioTools (LAB) competitors?
Other companies in Standard BioTools’s space includes: 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Sotera Health (NASDAQ:SHC).
What is the forecast, or price target, for Standard BioTools (LAB) stock?
Standard BioTools has a consensus price target of $3.25.
What is the current price for Standard BioTools (LAB)?
The stock price for Standard BioTools (NASDAQ: LAB) is $2.19 last updated December 18, 2024 at 9:30 AM EST.
Does Standard BioTools (LAB) pay a dividend?
There are no upcoming dividends for Standard BioTools.
When is Standard BioTools (NASDAQ:LAB) reporting earnings?
Standard BioTools’s Q4 earnings are confirmed for Wednesday, February 26, 2025.
Is Standard BioTools (LAB) going to split?
There is no upcoming split for Standard BioTools.
What sector and industry does Standard BioTools (LAB) operate in?
Standard BioTools is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.